The case for epigenomics in idiopathic pulmonary fibrosis

[1]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[2]  Mark Groudine,et al.  Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells , 2004, Nature Structural &Molecular Biology.

[3]  S. Freier,et al.  Improved targeting of miRNA with antisense oligonucleotides , 2006, Nucleic acids research.

[4]  B. Weinhold.  Epigenetics: the science of change. , 2006, Environmental health perspectives.

[5]  D. Wion,et al.  N6-methyl-adenine: an epigenetic signal for DNA–protein interactions , 2006, Nature Reviews Microbiology.

[6]  J. M. Thomson,et al.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. , 2007, Developmental biology.

[7]  Peter A. Jones,et al.  Epigenetics and MicroRNAs , 2007, Pediatric Research.

[8]  G. Nuovo,et al.  Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. , 2008, American journal of respiratory cell and molecular biology.

[9]  F. Martinez,et al.  TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation , 2008, Histochemistry and Cell Biology.

[10]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[11]  Hai Hu,et al.  Efficiency Analysis of Competing Tests for Finding Differentially Expressed Genes in Lung Adenocarcinoma , 2008, Cancer informatics.

[12]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[13]  P. Barbry,et al.  Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions , 2009, PloS one.

[14]  W. Coward,et al.  Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary Fibrosis , 2009, Molecular and Cellular Biology.

[15]  J. Lasky,et al.  Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[16]  Young-Joon Kim,et al.  Nucleosome deposition and DNA methylation at coding region boundaries , 2009, Genome Biology.

[17]  Oliver Eickelberg,et al.  Inhibition and role of let-7d in idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[18]  Julia A. Lasserre,et al.  Histone modification levels are predictive for gene expression , 2010, Proceedings of the National Academy of Sciences.

[19]  S. Zhuang,et al.  Antinociceptive Interactions between Mu-Opioid Receptor Agonists and the Serotonin Uptake Inhibitor Clomipramine in Rhesus Monkeys: Role of Mu Agonist Efficacy , 2010, Journal of Pharmacology and Experimental Therapeutics.

[20]  W. Coward,et al.  Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis , 2010, Molecular and Cellular Biology.

[21]  Guoping Fan,et al.  DNA methylation in cell differentiation and reprogramming: an emerging systematic view. , 2010, Regenerative medicine.

[22]  N. Kaminski,et al.  miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis , 2010, The Journal of experimental medicine.

[23]  David R. Liu,et al.  The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing , 2010, PloS one.

[24]  Biao Hu,et al.  Epigenetic regulation of myofibroblast differentiation by DNA methylation. , 2009, The American journal of pathology.

[25]  E. White,et al.  Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. , 2010, The American journal of pathology.

[26]  Matej Oresic,et al.  Multivariate multi-way analysis of multi-source data , 2010, Bioinform..

[27]  I. Oglesby,et al.  MicroRNAs in inflammatory lung disease - master regulators or target practice? , 2010, Respiratory research.

[28]  Thomas Lengauer,et al.  Genomic Distribution and Inter-Sample Variation of Non-CpG Methylation across Human Cell Types , 2011, PLoS genetics.

[29]  Thomas A. Wynn,et al.  Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.

[30]  J. Qian,et al.  miR-29 is a major regulator of genes associated with pulmonary fibrosis. , 2011, American journal of respiratory cell and molecular biology.

[31]  E. Rooij,et al.  The Art of MicroRNA Research , 2011 .

[32]  K. Kuwano,et al.  Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[33]  Ankur Kulshreshtha,et al.  Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. , 2011, The Journal of allergy and clinical immunology.

[34]  F. Martinez,et al.  A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis , 2011, PloS one.

[35]  Biao Hu,et al.  Essential role of Mecp2 in the regulation of myofibroblast differentiation , 2010, The American journal of pathology.

[36]  A. Ganesan,et al.  Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis. , 2012, American journal of respiratory cell and molecular biology.

[37]  Abraham J. Khorasani,et al.  Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma , 2012, Cell.

[38]  Z. Yakhini,et al.  Global Methylation Patterns in Idiopathic Pulmonary Fibrosis , 2012, PloS one.

[39]  F. Martinez,et al.  Epigenetic mechanisms through which Toll-like receptor-9 drives idiopathic pulmonary fibrosis progression. , 2012, Proceedings of the American Thoracic Society.

[40]  T. Jenuwein,et al.  In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases , 2012, PLoS genetics.

[41]  M. Kahn,et al.  Profibrotic role of miR-154 in pulmonary fibrosis. , 2012, American journal of respiratory cell and molecular biology.

[42]  C. Watson,et al.  Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype , 2012, Respiratory Research.

[43]  DNA methylation and transcriptional noise , 2013, Epigenetics & Chromatin.

[44]  S. Matalon,et al.  Participation of miR-200 in pulmonary fibrosis. , 2012, The American journal of pathology.

[45]  J. Stenvang,et al.  Inhibition of microRNA function by antimiR oligonucleotides , 2012, Silence.

[46]  E. van Rooij,et al.  Developing microRNA therapeutics. , 2012, Circulation research.

[47]  Xiangyu Zhang,et al.  Altered DNA methylation profile in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.

[48]  M. Selman,et al.  Hypermethylation‐Mediated Silencing of p14ARF in Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) , 2012, American journal of physiology. Lung cellular and molecular physiology.

[49]  O. Kovalchuk,et al.  Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis. , 2013, Trends in molecular medicine.

[50]  Nathan E Lewis,et al.  Analysis of omics data with genome-scale models of metabolism. , 2013, Molecular bioSystems.

[51]  H. Kubo,et al.  The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells , 2013, Respiratory Research.

[52]  E. Abraham,et al.  miR‐145 regulates myofibroblast differentiation and lung fibrosis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  A. Jackson,et al.  Reflections on microRNAs in chronic pulmonary disease: looking into the miR-ror and crystal ball. , 2013, Inflammation & allergy drug targets.

[54]  Tim Crook,et al.  Cancer Epigenetics: New Therapies and New Challenges , 2013, Journal of drug delivery.

[55]  T. Luedde,et al.  miR-199a-5p Is Upregulated during Fibrogenic Response to Tissue Injury and Mediates TGFbeta-Induced Lung Fibroblast Activation by Targeting Caveolin-1 , 2013, PLoS genetics.

[56]  G K Smyth,et al.  HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses , 2013, Cell Death and Disease.

[57]  Zachary D. Smith,et al.  DNA methylation: roles in mammalian development , 2013, Nature Reviews Genetics.

[58]  Carmen Z. Cantemir-Stone,et al.  Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis. , 2013, American journal of respiratory and critical care medicine.

[59]  Brent S. Pedersen,et al.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.

[60]  E. White,et al.  Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts , 2013, Cell Death and Disease.

[61]  Carla M. T. Bauer,et al.  BET Bromodomain Proteins Mediate Downstream Signaling Events following Growth Factor Stimulation in Human Lung Fibroblasts and Are Involved in Bleomycin-Induced Pulmonary Fibrosis , 2013, Molecular Pharmacology.

[62]  C. Stevenson,et al.  Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis. , 2013, The American journal of pathology.

[63]  P. Hergert,et al.  Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1. , 2013, The American journal of pathology.

[64]  Hui Liu,et al.  Histone Deacetylase Inhibition Downregulates Collagen 3A1 in Fibrotic Lung Fibroblasts , 2013, International journal of molecular sciences.

[65]  Ping Li,et al.  Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

[66]  E. White,et al.  miR-92a regulates TGF-β1-induced WISP1 expression in pulmonary fibrosis. , 2014, The international journal of biochemistry & cell biology.

[67]  Juan Li,et al.  Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis. , 2014, International journal of molecular medicine.

[68]  N. Ambalavanan,et al.  Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice , 2014, European Respiratory Journal.

[69]  Avrum Spira,et al.  Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. , 2014, American journal of respiratory and critical care medicine.

[70]  H. Shan,et al.  Integrated analyses identify the involvement of microRNA-26a in epithelial–mesenchymal transition during idiopathic pulmonary fibrosis , 2014, Cell Death and Disease.

[71]  R. Nho,et al.  MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[72]  Steven K. Huang,et al.  Lung Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis Exhibit Genome-Wide Differences in DNA Methylation Compared to Fibroblasts from Nonfibrotic Lung , 2014, PloS one.

[73]  M. Nireekshan Kumar,et al.  MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis. , 2014, American journal of respiratory cell and molecular biology.

[74]  W. Coward,et al.  A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  Chaoqian Xu,et al.  The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[76]  Gang Liu,et al.  Epigenetic mechanisms regulate NADPH oxidase-4 expression in cellular senescence. , 2015, Free radical biology & medicine.

[77]  X. Gou,et al.  Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition. , 2015, Archives of biochemistry and biophysics.

[78]  C. Singer,et al.  Epigenetic targets for novel therapies of lung diseases. , 2015, Pharmacology & therapeutics.